GHK-Cu
Copper tripeptide (glycyl-histidyl-lysine copper complex)
Copper peptide studied in dermal remodeling and cosmetics.
Back to technical sheets- Class
- Copper tripeptide (glycyl-histidyl-lysine copper complex)
- Also known as
- Topical cosmetic use; not an approved systemic drug
Mechanism of action
Copper complex with proposed effects on extracellular-matrix remodeling, antioxidant activity and collagen synthesis. Evidence is mostly topical and in vitro.
Evidence
Topical cosmetic use with in-vitro and small dermal clinical studies. It is not an approved systemic drug. Preclinical for systemic uses.
Studied uses
- Topical skin care / cosmeceuticals
Safety considerations
- Limited systemic data
- Possible topical irritation
- Not approved as a systemic drug
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Purity
- ≥ 99 % (HPLC)
- Net content
- 88 %
- Batch
- GHK-2601
- Presentation
- Polvo liofilizado en vial sellado
Net content is the fraction of the vial’s weight that is actually peptide, after discounting water, salts and excipients. It is the figure to calculate with, not the label weight.
Sample prices and batch data while the real ones are loaded.
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.